Enhancing Smoking Cessation for African American People Everywhere
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Houston
About this trial
The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.
Eligibility criteria
Qualifiers
At least 18 years of age
Identify as Black/African American
Living with HIV
Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement
Disqualifiers
Legal situations which may interfere with study participation
Not being fluent in English
High blood pressure that is not under control
Having experienced a heart attack within the past 2 weeks
Trial design
Treatments tested in this trial
- ESCAPE app + NRT
- quiSTART app + NRT
- Control (CTRL)
Treatment groups
300 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Houston
Lead sponsor
University of Oklahoma
Collaborator
Source ClinicalTrials.gov